XML 15 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900
CHINA GEWANG BIOTECHNOLOGY, INC.- Consolidated Balance Sheets - USD ($)
Nov. 30, 2015
Nov. 30, 2014
Current Assets:    
Cash $ 8,669,034 $ 3,012,812
Accounts receivable 267,868 0
Inventory 156,778 53,996
Prepaid expenses 201,369 105,200
Total current assets 9,295,049 3,172,008
Property, plant and equipment, net 65,860 48,184
Total Assets 9,360,909 3,220,192
Current Liabilities:    
Advance from customers   56,930
Accounts payable   7,225
Taxes payable 64,153 47,329
Accrued expenses and other payable 175,086 3,839
Loans from stockholders 166,106 6,417
TOTAL CURRENT LIABILITIES 405,345 121,740
Stockholders' equity:    
Common stock [1] 45,500 35,500
Additional paid-in capital 6,525,743 1,539,275
Retained earnings 2,270,416 1,277,273
Statutory reserve fund 281,766 144,454
Other comprehensive (loss) income (252,022) 62,998
Stockholders' equity before noncontrolling interests 8,871,403 3,059,500
Noncontrolling interests 84,161 38,952
Total Stockholders' equity 8,957,564 3,098,452
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 9,360,909 $ 3,220,192
[1] $0.001 par value, 75,000,000 shares authorized; 45,500,000 shares issued and outstanding as of November 30, 2015 and 35,500,000 shares issued and outstanding as of November 30, 2014